New Drug safety Regulations churn out jobs for pharmaceutical professionals
The Chinese government has taken a move to make drug safety regulations more stringent in China, so has the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMEA). In the new drug safety regulations move by the FDA, a need for post marketing surveillance has been stressed. This means that the safety status of medicines which are marketed need will be tracked regularly and checked if the details adhere to the norms of drug safety regulations. Industry experts have pointed out that this move will aggravate job openings in the pharmaceutical industry who anticipate a sudden and urgent requirement of pharmaceutical professionals.
These freshly recruited people undertake the task of quality assurance of drugs in drug stores post marketing. It is clear that applicants with pharmaceutical background and those who have experience in pharmaceutical firms will be given preference. But will they work for the government or for pharmaceutical firms is something that needs to be mused on. Any which way, the large need for pharmaceutical professionals created by this government move comes as a blessing for all those who are looking for pharmaceutical related jobs. It is also a blessing for all the consumers who can now rest assured that the drugs they buy is free from harm. The entire plan has been splint into 4 phases in order to increase efficiency and reduce cost. It is also designed to bring enhance transparency and avoid cases of mishaps and complaints directed at poor quality of drugs. The work on this expected to begin soon, the first thing being recruitment of personnel to execute the plan.
The new safety regulation module is sure to make purchase of prescription drugs safe and foolproof. In tough times that the world economy is going through the job openings created will water the job drought. It's a win-win situation for both parties.
About the Author:
I am a pharmaceutical professional employed in drug company. I have been following up on the latest developments in drug safety pharmacovigilance and other drug registration software news which I have put forth in my article.
